In vitro drug release testing of controlled release veterinary drug products

Publisher Summary The purpose of this chapter is to discuss various aspects of in vitro drug release test method development, optimization, and validation. It discusses both compendia and non-compendia methods and provides suggestions to achieve sound, scientific development, and validation for such methods. A controlled release veterinary pharmaceutical is specifically designed to release its contents over an extended period at a predefined rate. The release characteristics of the product are dependent upon its formulation and the process conditions used during its manufacture. Manufacturers need some method that allows them to determine the effect of formulation and manufacturing variables on release rate. It is important to develop an inexpensive, rapid, and reproducible test that assesses the drug release characteristics of the product in vitro, but which provides assurances to manufacturers and regulatory bodies of the batch-to-batch in vivo performance of the product.

[1]  S. Qureshi,et al.  Application of flow-through dissolution method for the evaluation of oral formulations of nifedipine , 1994 .

[2]  M. Gibaldi,et al.  Solubilization and rate of dissolution of drugs in the presence of physiologic concentrations of lysolecithin. , 1967, Journal of pharmaceutical sciences.

[3]  D. J. Stelzer,et al.  Deaeration Techniques For Dissolution Media , 1995 .

[4]  M. Siewert FIP Guidelines for Dissolution Testing of Solid Oral Products (Final Draft, 1995) , 1996 .

[5]  J. W. Skoug,et al.  Strategy for the development and validation of dissolution tests for solid oral dosage forms , 1996 .

[6]  I. Khan,et al.  Dissolution testing for sustained or controlled release oral dosage forms and correlation with in vivo data: Challenges and opportunities , 1996 .

[7]  L. Lesko,et al.  Current Challenges and Future Regulatory Directions in In Vitro Dissolution , 1995 .

[8]  Vinod P. Shah,et al.  In vitro dissolution of sparingly water-soluble drug dosage forms , 1995 .

[9]  W. Higuchi,et al.  Dissolution kinetics of cholesterol in simulated bile I: Influence of bile acid type and concentration, bile acid-lecithin ration, and added electrolyte. , 1977, Journal of pharmaceutical sciences.

[10]  C. D. Lathia,et al.  Advances in Dissolution Technology: Design, Pros and Cons , 1986 .

[11]  M. Gibaldi,et al.  Rate of Dissolution of Griseofulvin and Hexoestrol in Bile Salt Solutions , 1966, Nature.

[12]  M. Gibaldi,et al.  Solubilizing properties of bile salt solutions. II. Effect of inorganic electrolyte, lipids, and a mixed bile salt system on solubilization of glutethimide, griseofulvin, and hexestrol. , 1966, Journal of pharmaceutical sciences.

[13]  F. Langenbucher in vitroとin vivoの薬物利用率を関連づける手段としての数字であらわしたコンボルューションとデコンボルューション , 1982 .

[14]  G. R. Dukes,et al.  SPECIFICATION DEVELOPMENT AND STABILITY ASSESSMENT , 1998 .

[15]  I. Kanfer,et al.  Level a in Vitro/in Vivo Correlations: A Quality Control Tool or Bioequivalence Predictor for Extended-Release Solid Oral Dosage Forms? , 1995 .

[16]  C. E. Wells Effect of sampling probe size on dissolution of tableted drug samples. , 1981, Journal of pharmaceutical sciences.

[17]  W. Higuchi,et al.  Mechanistic study of the influence of micelle solubilization and hydrodynamic factors on the dissolution rate of solid drugs. , 1968, Journal of pharmaceutical sciences.

[18]  B. Rohrs,et al.  USP dissolution apparatus 3 (reciprocating cylinder): instrument parameter effects on drug release from sustained release formulations. , 1995, Journal of pharmaceutical sciences.

[19]  P. Welling,et al.  In Vitro-in Vivo Correlations — Quo Vadis , 1995 .

[20]  Lewis J. Leeson,et al.  In Vitro/In Vivo Correlations , 1995 .

[21]  E. Jorgensen,et al.  Development of dissolution tests for oral extended-release products , 1998 .

[22]  H. Möller,et al.  Regulatory aspects of modified release dosage forms: special cases of dissolution testing using the flow-through system. , 1993, Bollettino chimico farmaceutico.

[23]  S. Ugwu,et al.  New and Extended Applications for USP Drug Release Apparatus 3. , 1997 .

[24]  C. E. Wells,et al.  Automated sampling of in vitro dissolution medium: effect of sampling probes on dissolution rate of prednisone tablets. , 1982, Journal of pharmaceutical sciences.

[25]  N. Gochman,et al.  Effect of a detergent on gastrointestinal absorption of a steroid. , 1961, Lancet.